HOT-HMV reduced 12 month acute exacerbation risk by more than one third - Activity One - Presentation:<br>Preventing Admission in Severe COPD: Clinical Implications of the HOT-HMV Trial - Resource Center:<br>Effective Management of Advanced COPD Patients Post-acute Care